Skip to main content
Erschienen in: Journal of Neurology 9/2012

01.09.2012 | Original Communication

Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion

verfasst von: G. Koutsis, G. Karadima, A. Pandraud, M. G. Sweeney, R. Paudel, H. Houlden, N. W. Wood, M. Panas

Erschienen in: Journal of Neurology | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Huntington’s disease (HD) is an autosomal dominant disorder characterized by a triad of chorea, psychiatric disturbance and cognitive decline. Around 1% of patients with HD-like symptoms lack the causative HD expansion and are considered HD phenocopies. Genetic diseases that can present as HD phenocopies include HD-like syndromes such as HDL1, HDL2 and HDL4 (SCA17), some spinocerebellar ataxias (SCAs) and dentatorubral-pallidoluysian atrophy (DRPLA). In this study we screened a cohort of 21 Greek patients with HD phenocopy syndromes for mutations causing HDL2, SCA17, SCA1, SCA2, SCA3, SCA8, SCA12 and DRPLA. Fifteen patients (71%) had a positive family history. We identified one patient (4.8% of the total cohort) with an expansion of 81 combined CTA/CTG repeats at the SCA8 locus. This falls within what is believed to be the high-penetrance allele range. In addition to the classic HD triad, the patient had features of dystonia and oculomotor apraxia. There were no cases of HDL2, SCA17, SCA1, SCA2, SCA3, SCA12 or DRPLA. Given the controversy surrounding the SCA8 expansion, the present finding may be incidental. However, if pathogenic, it broadens the phenotype that may be associated with SCA8 expansions. The absence of any other mutations in our cohort is not surprising, given the low probability of reaching a genetic diagnosis in HD phenocopy patients.
Literatur
1.
Zurück zum Zitat Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83–98PubMedCrossRef Ross CA, Tabrizi SJ (2011) Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10:83–98PubMedCrossRef
2.
Zurück zum Zitat The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRef The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983CrossRef
3.
Zurück zum Zitat Squitieri F, Berardelli A, Nargi E, Castellotti B, Mariotti C, Cannella M et al (2000) Atypical movement disorders in the early stages of Huntington’s disease: clinical and genetic analysis. Clin Genet 58:50–56PubMedCrossRef Squitieri F, Berardelli A, Nargi E, Castellotti B, Mariotti C, Cannella M et al (2000) Atypical movement disorders in the early stages of Huntington’s disease: clinical and genetic analysis. Clin Genet 58:50–56PubMedCrossRef
4.
Zurück zum Zitat Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J et al (1994) A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 330:1401–1406PubMedCrossRef Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, Zeisler J et al (1994) A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 330:1401–1406PubMedCrossRef
5.
Zurück zum Zitat Wild EJ, Tabrizi SJ (2007) Huntington’s disease phenocopy syndromes. Curr Opin Neurol 20:681–687PubMedCrossRef Wild EJ, Tabrizi SJ (2007) Huntington’s disease phenocopy syndromes. Curr Opin Neurol 20:681–687PubMedCrossRef
6.
Zurück zum Zitat Schneider SA, Walker RH, Bhatia KP (2007) The Huntington’s disease-like syndromes: what to consider in patients with a negative Huntington’s disease gene test. Nat Clin Pract Neurol 3:517–525PubMedCrossRef Schneider SA, Walker RH, Bhatia KP (2007) The Huntington’s disease-like syndromes: what to consider in patients with a negative Huntington’s disease gene test. Nat Clin Pract Neurol 3:517–525PubMedCrossRef
7.
Zurück zum Zitat Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C et al (2003) Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603PubMedCrossRef Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C et al (2003) Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603PubMedCrossRef
8.
Zurück zum Zitat Keckarević M, Savić D, Svetel M, Kostić V, Vukosavić S, Romac S (2005) Yugoslav HD phenocopies analyzed on the presence of mutations in PrP, ferritin, and Jp-3 genes. Int J Neurosci 115:299–301PubMedCrossRef Keckarević M, Savić D, Svetel M, Kostić V, Vukosavić S, Romac S (2005) Yugoslav HD phenocopies analyzed on the presence of mutations in PrP, ferritin, and Jp-3 genes. Int J Neurosci 115:299–301PubMedCrossRef
9.
Zurück zum Zitat Costa Mdo C, Teixeira-Castro A, Constante M, Magalhães M, Magalhães P, Cerqueira J et al (2006) Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 51:645–651PubMedCrossRef Costa Mdo C, Teixeira-Castro A, Constante M, Magalhães M, Magalhães P, Cerqueira J et al (2006) Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 51:645–651PubMedCrossRef
10.
Zurück zum Zitat Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP et al (2008) Huntington’s disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23:716–720PubMedCrossRef Wild EJ, Mudanohwo EE, Sweeney MG, Schneider SA, Beck J, Bhatia KP et al (2008) Huntington’s disease phenocopies are clinically and genetically heterogeneous. Mov Disord 23:716–720PubMedCrossRef
11.
Zurück zum Zitat Sułek-Piatkowska A, Krysa W, Zdzienicka E, Szirkowiec W, Hoffman-Zacharska D, Rajkiewicz M et al (2008) Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington’s disease and without mutation in the IT15 gene. Neurol Neurochir Pol 42:203–209PubMed Sułek-Piatkowska A, Krysa W, Zdzienicka E, Szirkowiec W, Hoffman-Zacharska D, Rajkiewicz M et al (2008) Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington’s disease and without mutation in the IT15 gene. Neurol Neurochir Pol 42:203–209PubMed
12.
Zurück zum Zitat Rodrigues GR, Walker RH, Bader B, Danek A, Brice A, Cazeneuve C et al (2011) Clinical and genetic analysis of 29 Brazilian patients with Huntington’s disease-like phenotype. Arq Neuropsiquiatr 69:419–423PubMedCrossRef Rodrigues GR, Walker RH, Bader B, Danek A, Brice A, Cazeneuve C et al (2011) Clinical and genetic analysis of 29 Brazilian patients with Huntington’s disease-like phenotype. Arq Neuropsiquiatr 69:419–423PubMedCrossRef
13.
Zurück zum Zitat Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K et al (2010) Huntington’s disease in Greece: the experience of 14 years. Clin Genet 80:586–590PubMedCrossRef Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K et al (2010) Huntington’s disease in Greece: the experience of 14 years. Clin Genet 80:586–590PubMedCrossRef
14.
Zurück zum Zitat Vincent JB, Yuan QP, Schalling M, Adolfsson R, Azevedo MH, Macedo A et al (2000) Long repeat tracts at SCA8 in major psychosis. Am J Med Genet 96:873–876PubMedCrossRef Vincent JB, Yuan QP, Schalling M, Adolfsson R, Azevedo MH, Macedo A et al (2000) Long repeat tracts at SCA8 in major psychosis. Am J Med Genet 96:873–876PubMedCrossRef
15.
Zurück zum Zitat Juvonen V, Hietala M, Päivärinta M, Rantamäki M, Hakamies L, Kaakkola S et al (2000) Clinical and genetic findings in finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol 48:354–361PubMedCrossRef Juvonen V, Hietala M, Päivärinta M, Rantamäki M, Hakamies L, Kaakkola S et al (2000) Clinical and genetic findings in finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol 48:354–361PubMedCrossRef
16.
Zurück zum Zitat Gupta A, Jankovic J (2009) Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord 15:621–626PubMedCrossRef Gupta A, Jankovic J (2009) Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord 15:621–626PubMedCrossRef
17.
Zurück zum Zitat Semaka A, Creighton S, Warby S, Hayden MR (2006) Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 70:283–294PubMedCrossRef Semaka A, Creighton S, Warby S, Hayden MR (2006) Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 70:283–294PubMedCrossRef
18.
Zurück zum Zitat Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O’Hearn E, Ross CA et al (2004) Huntington’s Disease-like 2 (HDL2) in North America and Japan. Ann Neurol 56(5):670–674PubMedCrossRef Margolis RL, Holmes SE, Rosenblatt A, Gourley L, O’Hearn E, Ross CA et al (2004) Huntington’s Disease-like 2 (HDL2) in North America and Japan. Ann Neurol 56(5):670–674PubMedCrossRef
19.
20.
Zurück zum Zitat Ikeda Y, Daughters RS, Ranum LP (2008) Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes. Cerebellum 7:150–158PubMedCrossRef Ikeda Y, Daughters RS, Ranum LP (2008) Bidirectional expression of the SCA8 expansion mutation: one mutation, two genes. Cerebellum 7:150–158PubMedCrossRef
21.
Zurück zum Zitat Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK (2005) Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord 11:147–150PubMedCrossRef Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK (2005) Sporadic SCA8 mutation resembling corticobasal degeneration. Parkinsonism Relat Disord 11:147–150PubMedCrossRef
22.
Zurück zum Zitat Munhoz RP, Teive HA, Raskin S, Werneck LC (2009) CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 111:208–210PubMedCrossRef Munhoz RP, Teive HA, Raskin S, Werneck LC (2009) CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg 111:208–210PubMedCrossRef
23.
Zurück zum Zitat Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC et al (2004) Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet 65:209–214PubMedCrossRef Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC et al (2004) Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet 65:209–214PubMedCrossRef
24.
Zurück zum Zitat Day JW, Schut LJ, Moseley ML, Durand AC, Ranum LPW (2000) Spinocerebellar ataxia type 8. Clinical features in a large family. Neurology 55:649–657PubMedCrossRef Day JW, Schut LJ, Moseley ML, Durand AC, Ranum LPW (2000) Spinocerebellar ataxia type 8. Clinical features in a large family. Neurology 55:649–657PubMedCrossRef
25.
Zurück zum Zitat Ito H, Kawakami H, Wate R, Matsumoto S, Imai T, Hirano A et al (2006) Clinicopathologic investigation of a family with expanded SCA8 CTA/CTG repeats. Neurology 67:1479–1481PubMedCrossRef Ito H, Kawakami H, Wate R, Matsumoto S, Imai T, Hirano A et al (2006) Clinicopathologic investigation of a family with expanded SCA8 CTA/CTG repeats. Neurology 67:1479–1481PubMedCrossRef
27.
Zurück zum Zitat Worth PF, Houlden H, Giunti P, Davis MB, Wood NW (2000) Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat Genet 24:214–215PubMedCrossRef Worth PF, Houlden H, Giunti P, Davis MB, Wood NW (2000) Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat Genet 24:214–215PubMedCrossRef
28.
Zurück zum Zitat Stevanin G, Herman A, Dürr A, Jodice C, Frontali M, Agid Y, Brice A (2000) Are (CTG)n expansions at the SCA8 locus rare polymorphisms? Nat Genet 24:213PubMedCrossRef Stevanin G, Herman A, Dürr A, Jodice C, Frontali M, Agid Y, Brice A (2000) Are (CTG)n expansions at the SCA8 locus rare polymorphisms? Nat Genet 24:213PubMedCrossRef
29.
Zurück zum Zitat Schöls L, Bauer I, Zühlke C, Schulte T, Kölmel C, Bürk K et al (2003) Do CTG expansions at the SCA8 locus cause ataxia? Ann Neurol 54:110–115PubMedCrossRef Schöls L, Bauer I, Zühlke C, Schulte T, Kölmel C, Bürk K et al (2003) Do CTG expansions at the SCA8 locus cause ataxia? Ann Neurol 54:110–115PubMedCrossRef
30.
Zurück zum Zitat Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T et al (2004) Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 75:3–16PubMedCrossRef Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T et al (2004) Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet 75:3–16PubMedCrossRef
31.
Zurück zum Zitat Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS et al (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38:758–769PubMedCrossRef Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS et al (2006) Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 38:758–769PubMedCrossRef
32.
Zurück zum Zitat Daughters RS, Tuttle DL, Gao W, Ikeda Y, Moseley ML, Ebner TJ et al. (2009) RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet;5:e1000600. Epub 2009 Aug 14 Daughters RS, Tuttle DL, Gao W, Ikeda Y, Moseley ML, Ebner TJ et al. (2009) RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet;5:e1000600. Epub 2009 Aug 14
Metadaten
Titel
Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion
verfasst von
G. Koutsis
G. Karadima
A. Pandraud
M. G. Sweeney
R. Paudel
H. Houlden
N. W. Wood
M. Panas
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 9/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6430-9

Weitere Artikel der Ausgabe 9/2012

Journal of Neurology 9/2012 Zur Ausgabe

Pioneers in Neurology

Erwin Stransky (1877–1962)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.